Dr. Tareq Al Baghdadi
Claim this profileGenesys Hurley Cancer Institute
About Tareq Al Baghdadi
Education:
- Earned a Medical Degree (MD) from an unspecified medical school.
- Completed a Residency in Internal Medicine at Saint Joseph Mercy Hospital, also serving as Chief Resident.
- Undertook a Fellowship in Cardiovascular Disease at Saint Joseph Mercy Hospital.
Experience:
- N/A
Area of expertise
Cancer
Tareq Al Baghdadi has run 18 trials for Cancer. Some of their research focus areas include:
Pancreatic Cancer
Tareq Al Baghdadi has run 11 trials for Pancreatic Cancer. Some of their research focus areas include:
Affiliated Hospitals
Genesys Hurley Cancer Institute
Trinity Health Saint Mary Mercy Livonia Hospital
Clinical Trials Tareq Al Baghdadi is currently running
Atezolizumab + Chemotherapy
for Neuroendocrine Carcinoma
This trial is testing a new treatment combining an immune-boosting drug with standard chemotherapy for patients with a specific type of aggressive cancer that has spread. The goal is to help the immune system fight the cancer and use chemotherapy to kill cancer cells.
Recruiting
1 award
Phase 2 & 3
10 criteria
Venetoclax + HMA
for Acute Myeloid Leukemia
This phase II MyeloMATCH treatment trial compares the usual treatment of azacitidine and venetoclax to the combination treatment of azacitidine, venetoclax and gilteritinib in treating older and unfit patients with acute myeloid leukemia and FLT3 mutations. Azacitidine is a drug that is absorbed into DNA and leads to the activation of cancer suppressor genes, which are genes that help control cell growth. Venetoclax is in a class of medications called B-cell lymphoma-2 (BCL-2) inhibitors. It may stop the growth of cancer cells by blocking Bcl-2, a protein needed for cancer cell survival. Gilteritinib is in a class of medications called kinase inhibitors. It works by blocking the action of a certain naturally occurring substance that may be needed to help cancer cells multiply. This study may help doctors find out if these different approaches are better than the usual approaches. To decide if they are better, the study doctors are looking to see if the study drugs lead to a higher percentage of patients achieving a deeper remission compared to the usual approach.
Recruiting
1 award
Phase 2
7 criteria
More about Tareq Al Baghdadi
Clinical Trial Related
9 years of experience running clinical trials · Led 73 trials as a Principal Investigator · 25 Active Clinical Trials
Treatments Tareq Al Baghdadi has experience with
- Pembrolizumab
- Atezolizumab
- Cisplatin
- Nivolumab
- Fluorouracil
- Carboplatin
Breakdown of trials Tareq Al Baghdadi has run
Cancer
Pancreatic Cancer
Lung Cancer
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Tareq Al Baghdadi specialize in?
Tareq Al Baghdadi focuses on Cancer and Pancreatic Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are KRAS positive.
Is Tareq Al Baghdadi currently recruiting for clinical trials?
Yes, Tareq Al Baghdadi is currently recruiting for 25 clinical trials in Flint Michigan. If you're interested in participating, you should apply.
Are there any treatments that Tareq Al Baghdadi has studied deeply?
Yes, Tareq Al Baghdadi has studied treatments such as Pembrolizumab, Atezolizumab, Cisplatin.
What is the best way to schedule an appointment with Tareq Al Baghdadi?
Apply for one of the trials that Tareq Al Baghdadi is conducting.
What is the office address of Tareq Al Baghdadi?
The office of Tareq Al Baghdadi is located at: Genesys Hurley Cancer Institute, Flint, Michigan 48503 United States. This is the address for their practice at the Genesys Hurley Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.